- Ignalis M 50/500 mg Tablet provides dual-action glucose-lowering effects targeting both liver glucose output and pancreatic insulin response.
- This formulation significantly reduces HbA1c levels, aiding in achieving target glycaemic goals.
- Lower risk of hypoglycaemia compared to other diabetes medications like sulfonylureas.
- Weight-neutral profile minimizes the risk of weight gain associated with diabetes treatments.
- Favorable safety record with good tolerability in most patients using Ignalis M 50/500 mg Tablet.
- Simplified treatment regimen through a single combination tablet available in both immediate-release and extended-release formulations.
- Helps manage both fasting and postprandial blood glucose levels effectively.
- Reduces the risk of long-term complications related to type 2 diabetes, such as cardiovascular issues and neuropathy.
Ignalis M 50/500 mg Tablet - Strip of 10
Compositions : Sitagliptin 50mg + Metformin 500mg
MRP :
MRP :
Out of stock
Delivery within 2 to 7 Working Days
Manufacture/Marketer: Intas Pharmaceuticals Ltd.
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Description
Ignalis M 50/500 mg Tablet is a prescription medication specifically designed to assist adults in managing their blood sugar levels, particularly for those diagnosed with type 2 diabetes mellitus. This innovative formulation combines two active ingredients: Metformin and Sitagliptin, which work synergistically to enhance glucose regulation in the body. Metformin, a member of the biguanide class, functions by decreasing glucose production in the liver, improving insulin sensitivity, and slowing down the absorption of sugar from food within the intestines. On the other hand, Sitagliptin is classified as a dipeptidyl peptidase-4 (DPP-4) inhibitor, which elevates the levels of natural incretin hormones. These hormones play a crucial role in stimulating the pancreas to release more insulin post-meals while simultaneously reducing hepatic glucose production. The dual-action mechanism of Ignalis M 50/500 mg Tablet makes it an effective choice when lifestyle modifications such as diet and exercise, along with single-agent therapy, fail to achieve optimal blood sugar control. By utilizing both Metformin and Sitagliptin, Ignalis M 50/500 mg Tablet not only aids in lowering blood sugar levels throughout the day but also significantly reduces the risk of long-term complications associated with type 2 diabetes, including cardiovascular diseases, chronic kidney disease, and diabetic neuropathy. Regular monitoring of blood sugar levels and kidney function is essential during treatment with Ignalis M 50/500 mg Tablet to ensure safety and efficacy. Your healthcare provider will determine the most suitable dosage and formulation tailored to your specific needs, ensuring that you receive the best possible care in managing your diabetes.
Product Details
Ignalis M 50/500 mg Tablet operates through a combination of two active ingredients: Sitagliptin and Metformin. Sitagliptin enhances insulin production from the pancreas and reduces excess glucose generated by the liver. Metformin lowers glucose production in the liver and increases insulin sensitivity. Together, they provide comprehensive control over blood sugar levels.
- Take Ignalis M 50/500 mg Tablet with meals to minimize gastrointestinal discomfort.
- Typically prescribed once or twice daily based on your doctor's recommendations.
- Swallow extended-release tablets whole; do not crush or chew them.
- Maintain a consistent schedule by taking the medication at the same time each day.
- Regularly monitor your blood sugar levels as directed by your healthcare provider.
- Do not discontinue use of Ignalis M 50/500 mg Tablet without consulting your doctor first.
- Your doctor will determine the appropriate dosage tailored to your individual health needs.
- Incorporate regular physical activity into your daily routine to enhance blood sugar control while using Ignalis M 50/500 mg Tablet.
- Maintain a balanced diet rich in whole grains, fruits, vegetables, and lean proteins to support overall health.
- Avoid high-fat meals that may exacerbate gastrointestinal side effects associated with this medication.
- Carry a source of fast-acting sugar for emergencies in case of hypoglycemia episodes.
- Regularly check your feet for any sores or infections as part of diabetes management.
- Ensure annual kidney function tests are conducted while on Ignalis M 50/500 mg Tablet for ongoing safety monitoring.
Safety Advice
Side Effects
- Common side effects include stomach upset, nausea, diarrhea, and mild headaches.
- Cold-like symptoms such as a runny nose or sore throat may occur.
- Uncommon side effects may include skin rash, joint pain, changes in taste, or mild swelling of extremities.
- Serious side effects requiring immediate medical attention include lactic acidosis, characterized by severe fatigue, muscle pain, or difficulty breathing.
- Pancreatitis symptoms may include severe abdominal pain radiating to the back.
- Rare elevations in liver enzymes may necessitate monitoring during treatment with Ignalis M 50/500 mg Tablet.
- Consult your doctor if you experience any unusual symptoms while taking this medication.
Precautions and Warnings
- Avoid use of Ignalis M 50/500 mg Tablet if you have severe kidney or liver impairment.
- Consult your doctor before using this medication during pregnancy or breastfeeding.
- Monitor blood sugar levels regularly to prevent hypoglycemia, especially if combined with other diabetes medications.
- Limit alcohol consumption while taking Ignalis M 50/500 mg Tablet due to increased risk of lactic acidosis.
- Regular kidney function tests are recommended during treatment to ensure safety.
- If you experience symptoms of lactic acidosis such as rapid breathing or persistent nausea, seek medical help immediately.
FAQs
Ignalis M 50/500 mg Tablet is utilized for enhancing blood sugar control in adults diagnosed with type 2 diabetes. It is prescribed when lifestyle changes and single medications are insufficient.
2. How does Ignalis M 50/500 mg Tablet work?
This medication aids the body in utilizing insulin more effectively while also curbing excess glucose production from the liver. Its combined action improves overall blood sugar management.
3. When should I take Ignalis M 50/500 mg Tablet?
It is generally recommended to take this tablet with meals to reduce potential stomach upset. The timing may vary based on whether you are using an immediate or extended-release form.
4. How long does it take for Ignalis M 50/500 mg Tablet to lower blood sugar?
Initial improvements may be observed within a few days; however, significant benefits typically manifest over several weeks with consistent use.
5. Can Ignalis M 50/500 mg Tablet cause low blood sugar?
While it usually does not induce low blood sugar when used alone, combining it with insulin or certain other diabetes medications may increase this risk.
6. What are common side effects of Ignalis M 50/500 mg Tablet?
Common side effects include nausea, diarrhea, and mild stomach discomfort. These effects are often temporary and can improve over time.
7. Is Ignalis M 50/500 mg Tablet safe for long-term use?
Yes, it is frequently used long-term under medical supervision. Regular monitoring of blood sugar and kidney function is essential for safe use.
Instructions
Directions for Use
Storage and Disposal
More Information
| SKU | 162252 |
|---|---|
| Country of Manufacture | India |
| Manufacturer Address | Intas Pharmaceuticals Ltd. |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Storage | Please refer to the product label for storage information. |
| Seller | Kogland Commerce Pvt Ltd (TN) |
Ignalis M 50/500 mg Tablet is a prescription medication specifically designed to assist adults in managing their blood sugar levels, particularly for those diagnosed with type 2 diabetes mellitus. This innovative formulation combines two active ingredients: Metformin and Sitagliptin, which work synergistically to enhance glucose regulation in the body. Metformin, a member of the biguanide class, functions by decreasing glucose production in the liver, improving insulin sensitivity, and slowing down the absorption of sugar from food within the intestines. On the other hand, Sitagliptin is classified as a dipeptidyl peptidase-4 (DPP-4) inhibitor, which elevates the levels of natural incretin hormones. These hormones play a crucial role in stimulating the pancreas to release more insulin post-meals while simultaneously reducing hepatic glucose production. The dual-action mechanism of Ignalis M 50/500 mg Tablet makes it an effective choice when lifestyle modifications such as diet and exercise, along with single-agent therapy, fail to achieve optimal blood sugar control. By utilizing both Metformin and Sitagliptin, Ignalis M 50/500 mg Tablet not only aids in lowering blood sugar levels throughout the day but also significantly reduces the risk of long-term complications associated with type 2 diabetes, including cardiovascular diseases, chronic kidney disease, and diabetic neuropathy. Regular monitoring of blood sugar levels and kidney function is essential during treatment with Ignalis M 50/500 mg Tablet to ensure safety and efficacy. Your healthcare provider will determine the most suitable dosage and formulation tailored to your specific needs, ensuring that you receive the best possible care in managing your diabetes.
- Ignalis M 50/500 mg Tablet provides dual-action glucose-lowering effects targeting both liver glucose output and pancreatic insulin response.
- This formulation significantly reduces HbA1c levels, aiding in achieving target glycaemic goals.
- Lower risk of hypoglycaemia compared to other diabetes medications like sulfonylureas.
- Weight-neutral profile minimizes the risk of weight gain associated with diabetes treatments.
- Favorable safety record with good tolerability in most patients using Ignalis M 50/500 mg Tablet.
- Simplified treatment regimen through a single combination tablet available in both immediate-release and extended-release formulations.
- Helps manage both fasting and postprandial blood glucose levels effectively.
- Reduces the risk of long-term complications related to type 2 diabetes, such as cardiovascular issues and neuropathy.
Ignalis M 50/500 mg Tablet operates through a combination of two active ingredients: Sitagliptin and Metformin. Sitagliptin enhances insulin production from the pancreas and reduces excess glucose generated by the liver. Metformin lowers glucose production in the liver and increases insulin sensitivity. Together, they provide comprehensive control over blood sugar levels.
- Take Ignalis M 50/500 mg Tablet with meals to minimize gastrointestinal discomfort.
- Typically prescribed once or twice daily based on your doctor's recommendations.
- Swallow extended-release tablets whole; do not crush or chew them.
- Maintain a consistent schedule by taking the medication at the same time each day.
- Regularly monitor your blood sugar levels as directed by your healthcare provider.
- Do not discontinue use of Ignalis M 50/500 mg Tablet without consulting your doctor first.
- Your doctor will determine the appropriate dosage tailored to your individual health needs.
- Incorporate regular physical activity into your daily routine to enhance blood sugar control while using Ignalis M 50/500 mg Tablet.
- Maintain a balanced diet rich in whole grains, fruits, vegetables, and lean proteins to support overall health.
- Avoid high-fat meals that may exacerbate gastrointestinal side effects associated with this medication.
- Carry a source of fast-acting sugar for emergencies in case of hypoglycemia episodes.
- Regularly check your feet for any sores or infections as part of diabetes management.
- Ensure annual kidney function tests are conducted while on Ignalis M 50/500 mg Tablet for ongoing safety monitoring.
Side Effects
- Common side effects include stomach upset, nausea, diarrhea, and mild headaches.
- Cold-like symptoms such as a runny nose or sore throat may occur.
- Uncommon side effects may include skin rash, joint pain, changes in taste, or mild swelling of extremities.
- Serious side effects requiring immediate medical attention include lactic acidosis, characterized by severe fatigue, muscle pain, or difficulty breathing.
- Pancreatitis symptoms may include severe abdominal pain radiating to the back.
- Rare elevations in liver enzymes may necessitate monitoring during treatment with Ignalis M 50/500 mg Tablet.
- Consult your doctor if you experience any unusual symptoms while taking this medication.
Precautions and Warnings
- Avoid use of Ignalis M 50/500 mg Tablet if you have severe kidney or liver impairment.
- Consult your doctor before using this medication during pregnancy or breastfeeding.
- Monitor blood sugar levels regularly to prevent hypoglycemia, especially if combined with other diabetes medications.
- Limit alcohol consumption while taking Ignalis M 50/500 mg Tablet due to increased risk of lactic acidosis.
- Regular kidney function tests are recommended during treatment to ensure safety.
- If you experience symptoms of lactic acidosis such as rapid breathing or persistent nausea, seek medical help immediately.
Ignalis M 50/500 mg Tablet is utilized for enhancing blood sugar control in adults diagnosed with type 2 diabetes. It is prescribed when lifestyle changes and single medications are insufficient.
2. How does Ignalis M 50/500 mg Tablet work?
This medication aids the body in utilizing insulin more effectively while also curbing excess glucose production from the liver. Its combined action improves overall blood sugar management.
3. When should I take Ignalis M 50/500 mg Tablet?
It is generally recommended to take this tablet with meals to reduce potential stomach upset. The timing may vary based on whether you are using an immediate or extended-release form.
4. How long does it take for Ignalis M 50/500 mg Tablet to lower blood sugar?
Initial improvements may be observed within a few days; however, significant benefits typically manifest over several weeks with consistent use.
5. Can Ignalis M 50/500 mg Tablet cause low blood sugar?
While it usually does not induce low blood sugar when used alone, combining it with insulin or certain other diabetes medications may increase this risk.
6. What are common side effects of Ignalis M 50/500 mg Tablet?
Common side effects include nausea, diarrhea, and mild stomach discomfort. These effects are often temporary and can improve over time.
7. Is Ignalis M 50/500 mg Tablet safe for long-term use?
Yes, it is frequently used long-term under medical supervision. Regular monitoring of blood sugar and kidney function is essential for safe use.
Directions for Use
Storage and Disposal
| SKU | 162252 |
|---|---|
| Country of Manufacture | India |
| Manufacturer Address | Intas Pharmaceuticals Ltd. |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Storage | Please refer to the product label for storage information. |
| Seller | Kogland Commerce Pvt Ltd (TN) |
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Customer Reviews
No reviews yet
Be the first to share your thoughts. Honest feedback helps other shoppers and us serve you better.
Write Your Own Review
Only registered users can write reviews. Please Sign in or create an account